bf/NASDAQ:SMMT_icon.jpeg

NASDAQ:SMMT

Summit Therapeutics Inc.

  • Stock

USD

Last Close

3.74

27/03 20:00

Market Cap

2.63B

Beta: −1.02

Volume Today

1.42M

Avg: 2.06M

PE Ratio

−1.63

PFCF: −51.96

  • industry

    Biotechnology
  • exchange

    NASDAQ Global Market
  • website

    www.summittxinc.com
  • ipo date

    Mar 04, 2015
  • full time employees

    76
  • currency

    USD

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiot...Show More

Earnings

Earnings per Share (Estimate*)

-1122015-12-172017-08-312019-07-312021-05-172023-05-11

Revenue (Estimate*)

50M100M150M200M250M300M350M2015-12-172017-08-312019-07-312021-05-172023-05-11

*Estimate based on analyst consensus

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.